Source: Eur Respir J, 52 (3) 1701556; 10.1183/13993003.01556-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Hataitip Tasena, Alen Faiz, Wim Timens, Jacobien Noordhoek, Machteld N. Hylkema, Reinoud Gosens, Pieter S. Hiemstra, Avrum Spira, Dirkje S. Postma, Gaik W. Tew, Michele A. Grimbaldeston, Maarten van den Berge, Irene H. Heijink, Corry-Anke Brandsma. microRNA–mRNA regulatory networks underlying chronic mucus hypersecretion in COPD. Eur Respir J, 52 (3) 1701556; 10.1183/13993003.01556-2017

Member's Comments

No comment yet.

Related content which might interest you: Let-7 promotes airway remodeling via regulation of IL-6 in chronic obstruction pulmonary disease Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease Year: 2020 Overlapping biologic exacerbation clusters in asthma and chronic obstructive pulmonary disease have distinct sputum mediator and microbiome profiles Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Infectional factors influences on expressiveness of inflammatory process and structural changes in bronchial mucosa at COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 576s Year: 2006 MiR-320d has a regulatory effect in airway inflammation in COPD Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD Source: Eur Respir J 2015; 45: 60-75 Year: 2015 Longitudinal analysis of airway epithelium of COPD subjects reveals unique inflammatory gene networks up-regulated over time Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 A role for miR-708-5p in the regulation of chronic mucus hypersecretion Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Molecular phenotyping of chronic bronchitis: mucin and inflammatory gene expression heterogeneity in COPD Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: ERS Lung Science Conference 2017 Year: 2017 Differential response of COPD bronchial epithelium to LPS in a three-dimensional culture model Source: Annual Congress 2006 - Airway epithelial cells in inflammation Year: 2006 Cellular mechanisms underlying CCSP SNP association with chronic airway diseases Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD Source: ERJ Open Res, 4 (4) 00031-2018; 10.1183/23120541.00031-2018 Year: 2018 Profiling of healthy and asthmatic airway smooth muscle cells following interleukin-1ß treatment: a novel role for CCL20 in chronic mucus hypersecretion Source: Eur Respir J, 52 (2) 1800310; 10.1183/13993003.00310-2018 Year: 2018 Chronic persistence of human ?-herpesviruses and regulatory cells phenotypes in severe bronchial asthma. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts Source: International Congress 2016 – What's new in biomarker analysis? Year: 2016 The role of the frizzled-8 receptor in COPD with chronic mucus hypersecretion Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Revisited role for mucus hypersecretion in the pathogenesis of COPD Source: Eur Respir Rev 2009; 19: 109-112 Year: 2010 Dysregulation of serum miRNA in chronic obstructive pulmonary disease Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013